Respiratory Care Request for Proposals

Request for Proposals 2016

Respiratory Care and Neuromuscular Disorders

Download the
Application Form
Printable Version of RFP (.pdf)




  • Deadline to submit applications – Thursday June 30, 2016 at 11:59 pm (EST)
  • Peer Review – July/August 2016
  • Anticipated notice of decision – October 7, 2016
  • Funding start date – November 1, 2016

Back to top




Muscular Dystrophy Canada is a national, non-profit organization of dedicated volunteers and staff who continually work to provide support and resources to people impacted by neuromuscular disorders, and fund high-quality research striving to find better treatments, and a cure as soon as possible. We cover over 150 different types of neuromuscular disorders.

Respiratory health is a priority issue for people affected by neuromuscular disorders. Since 2012, Muscular Dystrophy Canada has focused on identifying the problems, gaps and opportunities to enhance education, awareness, clinical care, and research with respect to Respiratory Care.

The intent of this request is to solicit proposals related to improving respiratory health for people living with neuromuscular diseases. Projects should be carried out within a 12-month framework (beginning November 2016 or from date that ethics approval is obtained, if required), and have a budget between $25,000 – $50,000.

Back to top



The Importance of Respiratory Care

Many types of neuromuscular disorders have a progressive impact on the muscles required for airway clearance and good respiratory function. Respiratory care has a significant impact on the quality of life and longevity of many patients with a neuromuscular condition. For instance, respiratory failure is the number one cause of death among people with Duchenne muscular dystrophy, yet today there are preventative measures and interventions that can be beneficial in maintaining and prolonging comfort of life.

There are significant differences in government programs that provide access to ventilation supports, care and services across Canada. Many people who rely on invasive mechanical ventilation are unable to live in the community due to high costs and high care needs, and in these situations, individuals often unnecessarily reside in ICU or Long Term Care institutions. Prevention of secondary complex medical conditions is critical in order to prevent long term hospital admissions, loss of independence or life threatening conditions. Non-invasive ventilation, which poses a decreased risk of infection, is not universally accepted as the standard of care. Patients and health care providers both need to increase their awareness and understanding of ventilation options.

Back to top




The objectives of this initiative are to:

  • Increase and strengthen the body of knowledge available to prevent and treat respiratory issues for people living with neuromuscular disorders
  • Provide opportunities for collaboration between researchers and knowledge-users
  • Gather evidence that can help support other components of Muscular Dystrophy Canada’s respiratory care plan (e.g., education, advocacy, services)

Back to top




Lead applicants must hold an affiliation with a Canadian or international recognized academic institution. Eligible research institutions include those that are accepted under CIHR’s grant policies. Other institutions, including those outside of Canada, will be considered on an ad hoc basis as part of the peer review process, and may be required to provide additional documentation to support the application.

Private corporate entities are not eligible for funding.

Back to top



Funds Available

Muscular Dystrophy Canada has committed $150,000 to support the successful research projects. The maximum budget per project is $50,000. It is estimated that 3-5 proposals will be awarded funding.

Back to top




Projects must be directly relevant to respiratory health for people with neuromuscular disorders (applications not meeting this criterion will not be reviewed). This includes:

  • Prevention and early intervention strategies
  • Health services utilization
  • Usefulness of and access to therapies and equipment
  • Cost effectiveness studies
  • Assessment of educational and/or clinical interventions
  • Development and dissemination of standards of care
  • Advancement of best practices in care and treatment
  • Assessment of pilot training programs
  • Outcome measures
  • Development of an educational program module, with a clearly defined assessment component
  • Natural history studies
  • Evaluation of diagnostic tests

Proposals for knowledge translation projects must include a clearly defined assessment component.

Basic science projects would be considered out of scope.

Back to top




Allowable expenses include:

  • Salaries for staff engaged with the project, including administrative, technical, and student support staff
  • Costs for data and information collection
  • Travel
  • Communication related costs (meetings, phone calls)
  • Materials, supplies, consumables

Indirect expenses (i.e. payments towards general institutional overhead) are ineligible and therefore must be excluded from the budget.

Back to top



Evaluation Process and Criteria

Applications will be awarded through a competitive peer-review process. Proposals will be reviewed by Muscular Dystrophy’s Medical Science and Advisory Committee. Members will declare any conflict of interest with any application and excuse themselves from its review. Additional external expertise may be sought to enhance the review process (i.e., when gaps in expertise is noted or another opinion is beneficial or there is a conflict of interest).

Proposals will be reviewed taking into consideration factors including:

  • The potential of the proposed approach to achieve its objectives.
  • The achievements, potential, and track record of the applicant(s).
  • The feasibility of the proposed work plan, timelines and budget. Length of project should not exceed 12 months.
  • Objectives and scope of the project and relevance to the RFP.

Back to top



Guidelines and Conditions of Funding

  • Muscular Dystrophy Canada does not provide grant funds directly to the grantee; funds are distributed to the recipient’s institution, which will hold the funds and administer a specific account from which the grantee can draw upon.
  • The Principal Investigator will be responsible for providing a grant report and financial statement to Muscular Dystrophy Canada within 6 months of the end of the project.
  • Ethics approval is the responsibility of the researcher(s) within their affiliated institution(s).
  • Copyright and intellectual property will reside with the lead investigator unless otherwise negotiated.
  • Muscular Dystrophy Canada must be acknowledged as a funder of the project in all communications (including presentations, materials, publications, etc).
  • Muscular Dystrophy Canada has the right to publicize the grant, its investigator(s) and affiliate institution(s) in its communications vehicles, including annual reports, website, and other publications.
  • Muscular Dystrophy Canada may ask funded researcher(s) to present their work to donors, staff, Board and related committees or professional conferences to showcase their funded research.

Back to top



How to Apply

Send the completed application form to by Thursday June 30, 2016, 11:59 pm (EDT). In the body of the email, please include the title of the project, your contact details, and a list of attachments.

All submissions will receive an email acknowledgement upon receipt.

Back to top




Contact: Catherine Willinsky
Acting Director of Research, Muscular Dystrophy Canada.
Tel: 416-488-0030 ext 1103
Toll-Free: 1-866-687-2538

Back to top

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann